PCT testing is an effective way to avoid under- or over-utilization of antibiotics, reduce costs, and improve outcomes
PCT testing has helped health systems see impressive clinical and financial achievements
With PCT testing, health systems can help be a leader in antibiotic stewardship efforts
Procalcitonin for Antimicrobial Stewardship and the Management of Sepsis
by Nam K. Tran, PhD, MS, FACB, Director of Clinical Chemistry and POCT
Procalcitonin (PCT) is a peptide precursor to calcitonin that is associated with the inflammatory response to bacterial infection.
Multi-Center Clinical Study Confirms Decreased Levels of Procalcitonin as an Independent Predictor of Mortality in Patients with Severe Sepsis and Septic Shock
Thermo Fisher Scientific Inc. announces results from the multi-center Procalcitonin MOnitoring SEpsis (MOSES) Study have been published in the May 2017 print issue of Critical Care Medicine.
Procalcitonin-guided diagnosis and antibiotic stewardship revisited
Several controlled clinical studies have evaluated the potential of the infection biomarker procalcitonin (PCT) to improve the diagnostic work-up of patients with bacterial infections and its influence on decisions regarding antibiotic therapy.